Predictive factors of renal impairment in HIV-infected patients on antiretroviral therapy: Results from the VACH longitudinal cohort study

Samji, 2013, Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada, PLoS One, 8, e81355, 10.1371/journal.pone.0081355 Wang, 2016, Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980–2015: the Global Burden of Disease Study 2015, Lancet HIV, 3, e361, 10.1016/S2352-3018(16)30087-X Capeau, 2011, Premature aging and premature age-related comorbidities in HIV-infected patients: facts and hypotheses, Clin Infect Dis, 53, 1127, 10.1093/cid/cir628 Vance, 2015, Prediction of geriatric HIV in 2030, Lancet Infect Dis, 15, 753, 10.1016/S1473-3099(15)00063-8 Serrano-Villar, 2016, HIV as a chronic disease: evaluation and management of non-AIDS-defining conditions, Open Forum Infect Dis, 3, 10.1093/ofid/ofw097 Guaraldi, 2014, Morbidity in older HIV-infected patients: impact of long-term antiretroviral use, AIDS Rev, 16, 75 Hentzien, 2016, Impact of age-related comorbidities on five-year overall mortality among elderly HIV-infected patients in the late HAART era – role of chronic renal disease, J Nutr Health Aging, 20, 408, 10.1007/s12603-015-0608-7 Ryom, 2013, Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study, J Infect Dis, 207, 1359, 10.1093/infdis/jit043 Mocroft, 2016, Lancet HIV, 3, e23, 10.1016/S2352-3018(15)00211-8 Mocroft, 2010, Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients, AIDS, 24, 1667, 10.1097/QAD.0b013e328339fe53 VACH (Grupo Español de Estudios VIH/AICH). Available at: http://vach.es/. National Kidney Foundation, 2002, K/DOQI Clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification, Am J Kidney Dis, 39, 1 Levey, 2009, A new equation to estimate glomerular filtration rate, Ann Intern Med, 150, 604, 10.7326/0003-4819-150-9-200905050-00006 Levin, 2014, Summary of KDIGO 2012 CKD Guideline: behind the scenes, need for guidance, and a framework for moving forward, Kidney Int, 85, 49, 10.1038/ki.2013.444 Mocroft, 2015, Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study, PLoS Med, 12, e1001809, 10.1371/journal.pmed.1001809 Otero, 2010, Prevalence of chronic renal disease in Spain: results of the EPIRCE study, Nefrologia, 30, 78 Gayoso-Diz, 2013, Strategy to estimate risk progression of chronic kidney disease, cardiovascular risk, and referral to nephrology: the EPIRCE Study, Nefrologia, 33, 223 Ibrahim, 2012, Comparison of CKD-EPI and MDRD to estimate baseline renal function in HIV-positive patients, Nephrol Dial Transplant, 27, 2291, 10.1093/ndt/gfr657 Ibrahim, 2012, Study Group Baseline kidney function as predictor of mortality and kidney disease progression in HIV-positive patients, Am J Kidney Dis, 60, 539, 10.1053/j.ajkd.2012.03.006 DHHS. Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents (updated on March 13, 2017). Rodriguez-Nóvoa, 2010, Renal toxicity associated with tenofovir use, Expert Opin Drug Saf, 9, 545, 10.1517/14740331003627458 Arribas, 2017, A randomized, double-blind comparison of tenofovir alafenamide (TAF) vs. tenofovir disoproxil fumarate (TDF), each coformulated with elvitegravir, cobicistat, and emtricitabine (E/C/F) for initial HIV-1 treatment: week 144 results, J Acquir Immune Defic Syndr, 75, 211, 10.1097/QAI.0000000000001350 Rodríguez-Nóvoa, 2010, Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations, AIDS, 24, 1064, 10.1097/QAD.0b013e32833202e2 Casado, 2016, Renal and bone toxicity with the use of tenofovir: understanding at the end, AIDS Rev, 18, 59 Gedela, 2014, Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection, HIV Med, 15, 257, 10.1111/hiv.12116